FR 173657

Drug Profile

FR 173657

Alternative Names: FK 3657

Latest Information Update: 10 Sep 2003

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Fujisawa
  • Developer Fujisawa; Nonindustrial source
  • Class Analgesics; Anti-inflammatories; Antiasthmatics
  • Mechanism of Action Angiogenesis inhibitors; Bradykinin B2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Asthma; Cancer; Ulcerative colitis

Most Recent Events

  • 08 Jun 2001 No-Development-Reported for Asthma in Japan (PO)
  • 06 Apr 2001 A preclinical study has been added to the Cancer pharmacodynamics section
  • 02 Apr 2001 Preclinical development for Cancer in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top